Head-to-head · Value Score
CoreAge Rx vs Telos Rx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Telos Rx a 85. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameTelos Rx
#22 · Grade A- · Great Deal
Est. first month
$145/mo
Save ~89% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 85 — an est. $149/mo first month, with no teaser step-up baked in. Telos Rx isn't out of it: Committed shoppers willing to lock in 6–12 months to unlock genuinely rock-bottom compounded pricing, who want oral or microdosed options on one platform.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Telos Rx |
|---|---|---|
| Value Score | 93 (A+) | 85 (A-) |
| Est. first month | $149/mo | $145/mo |
| Save vs brand-name | ~89% | ~89% |
| Semaglutide | $149/mo | From $49/mo (annual) |
| Tirzepatide | $349/mo | From $99/mo (annual) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Not publicly listed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Telos Rx
Among the lowest published GLP-1 entry prices anywhere — microdosed semaglutide from $49/mo and tirzepatide from $99/mo — on a deep needle-free and oral menu, but the rock-bottom rates require a 6–12 month commitment, so the real month-to-month cost runs higher.
Why it's a deal
- Among the lowest published GLP-1 entry prices — microdosed sema from $49/mo and tirzepatide from $99/mo on annual plans
- Deep catalog including needle-free intranasal and oral/microdosed GLP-1 options
- LegitScript-certified and HIPAA-compliant, with HSA/FSA accepted and free 48-hour shipping
The fine print
- Rock-bottom prices require a 6–12 month commitment — real month-to-month cost is much higher ($145/$199/$399 first month)
- All compounded, not FDA-approved — and the research-grade peptides in its catalog have limited evidence
- Peptide and HRT pricing is hidden until you complete intake
- State list is not publicly published — confirm coverage before you sign up
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.